Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aprea Therapeutics (APRE) Q2 2024 Earnings
APRE
14
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.42
-1.17
-0.92
-0.67
Details
Expected EPS
-0.76
Actual EPS
-0.67
Surprise EPS
0.09
Surprise Percent
+11.84%
Description
Aprea Therapeutics (APRE) has reported earnings of -0.67 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login